Traductor

20 June 2011

Maintenance Therapy In Multiple Myeloma: CALGB & IFM Studies

Prof Gareth Morgan discusses the role of maintenance therapy across the multiple myeloma (MM) disease spectrum with Prof Antonio Palumbo and Dr Paul Richardson. The group discusses the recently reported Intergroup Phase III Study (CALGB 100104) which demonstrated an overall survival benefit with lenalidomide as continuous therapy for patients with newly diagnosed multiple myeloma following autologous stem cell transplantation.



No comments:

Post a Comment

CONTACTO · Aviso Legal · Política de Privacidad · Política de Cookies

Copyright © Noticia de Salud